Saturday 17 October 2026
Export DVA’s income statement to Excel — free account
DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
187.31
1.85
−0.98%
Follow DVA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (287.31%) | (323.64%) | 6,746.19% | 546.62% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 6 | 5 | |
| 4.81% | 4.51% | 4.30% | 4.40% | ||
ROIC |
13.90% | 13.75% | 13.71% | 13.96% | |
Return on Tangible Assets |
20.75% | 19.78% | 20.03% | 19.55% | |
Average Days of Receivables |
81.21 | 79.48 | 79.16 | 81.83 | |
Free Cash Flow per Share |
25.10 | 22.55 | 18.12 | 18.49 | |
Free Cash Flow |
1,625.97 | 1,519.92 | 1,344.81 | 1,332.57 | |
Capital Expenditures |
(567.19) | (507.40) | (541.69) | (560.83) | |
| Other line items | |||||
Cash ROIC |
14.64% | 13.84% | 12.36% | 12.31% | |
Accounts Receivable Turnover |
4.58 | 4.79 | 4.95 | 4.74 | |
Accounts Payable Turnover |
14.47 | 14.52 | 14.87 | 15.84 | |
Inventory Turnover |
63.64 | 63.98 | 62.63 | 67.58 | |
Average Days of Payables |
27.57 | 27.00 | 27.49 | 26.41 | |
Days of Inventory on Hand |
5.84 | 5.53 | 6.34 | 5.60 | |
Tax Rate |
(0.21) | (0.22) | (0.22) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.36% | 12.44% | 12.27% | 12.13% | |
Share Based Compensation of Revenue |
0.94% | 1.00% | 1.03% | 0.97% | |
Operating CF/Net income |
2.59 | 2.59 | 2.53 | 2.45 | |
Depreciation/Fixed assets |
0.26 | 0.26 | 0.25 | 0.25 | |
Capex/Depreciation |
(0.80) | (0.71) | (0.76) | (0.80) | |
Revenue per Share |
216.26 | 205.30 | 183.80 | 184.78 | |
Operating CF per Share |
33.85 | 30.08 | 25.42 | 26.27 | |
Capex per Share |
(8.76) | (7.53) | (7.30) | (7.78) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 |
Columns are period end dates